JV
Therapeutic Areas
Alaunos Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oral Non-Incretin Small Molecule | Obesity & Metabolic Disorders | Pre-clinical |
| TCR-T Cell Therapies (Platform) | Cancer (Solid Tumors) | Discovery/Platform |
Leadership Team at Alaunos Therapeutics
HW
Holger Weis
Chair of the Board of Directors, President of Weis Advisors, Inc.
CH
Curtis Hogue
Director